Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis
| Autor: | Masakazu Yamamoto, Yoriyuki Takamori, Giulio Belli, Seiki Kiriyama, Harumi Gomi, Cheng Hsi Su, Itaru Endo, Henry A. Pitt, Xiao Ping Chen, Koichi Hirata, Ho-Seong Han, Daniel J. Deziel, Yoshinobu Sumiyama, Yasuhisa Mori, Dong Sup Yoon, Tadahiro Takada, Yoshinori Noguchi, Keng Hao Liu, Koji Asai, Yukio Iwashita, Palepu Jagannath, Goro Honda, Seigo Kitano, David Schlossberg, Masamichi Yokoe, Yoo Seok Yoon, Toshihiko Mayumi, Naohisa Matsunaga, Eduardo de Santibañes, Eduard Jonas, Kui Hin Liau, Wayne Shih Wei Huang, In Seok Choi, Kohji Okamoto, Takao Itoi, O. James Garden, Mariano E Giménez, Ryota Higuchi, Akiko Umezawa, Tsann Long Hwang, Keita Wada, Masafumi Inomata, Masahiro Yoshida, Miin Fu Chen, Kenji Suzuki, Sheung Tat Fan, Joseph S. Solomkin, Tomohiko Ukai, Steven M. Strasberg, Fumihiko Miura, Satoru Shikata, Shuntaro Mukai, Christos Dervenis, Angus C.W. Chan, Dirk J. Gouma, Chen Guo Ker, Kazuo Inui, Taizo Hibi, Avinash Supe |
|---|---|
| Přispěvatelé: | Other departments |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Cholangitis Cholecystitis Acute Clinical Decision-Making Clinical settings Appropriate use 03 medical and health sciences 0302 clinical medicine Antibiotic resistance Acute cholecystitis Medicine Humans Intensive care medicine Tokyo Cholangiopancreatography Endoscopic Retrograde Endoscopic retrograde cholangiopancreatography Hepatology medicine.diagnostic_test business.industry Mobile apps medicine.disease Antimicrobial Anti-Bacterial Agents Community-Acquired Infections Treatment Outcome 030220 oncology & carcinogenesis Acute Disease Practice Guidelines as Topic Cholecystitis 030211 gastroenterology & hepatology Surgery Female business |
| Zdroj: | Journal of hepato-biliary-pancreatic sciences, 25(1), 3-16. Wiley-Blackwell |
| ISSN: | 1868-6982 |
| Popis: | Antimicrobial therapy is a mainstay of the management for patients with acute cholangitis and/or cholecystitis. The Tokyo Guidelines 2018 (TG18) provides recommendations for the appropriate use of antimicrobials for community-acquired and healthcare-associated infections. The listed agents are for empirical therapy provided before the infecting isolates are identified. Antimicrobial agents are listed by class-definitions and TG18 severity grade I, II, and III subcategorized by clinical settings. In the era of emerging and increasing antimicrobial resistance, monitoring and updating local antibiograms is underscored. Prudent antimicrobial usage and early de-escalation or termination of antimicrobial therapy are now important parts of decision-making. What is new in TG18 is that the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed. Prophylactic antimicrobial usage for elective endoscopic retrograde cholangiopancreatography is no longer recommended and the section was deleted in TG18. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text